| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |